title: Role of FDG-PET staging in selecting the optimum patient for hepatic resection of metastatic colorectal cancer.
abstract: Staging by FDG-PET of patients who are candidates for surgical treatment of colorectal metastases is an essential part of management of this problem. FDG-PET is highly sensitive and specific for intrahepatic colorectal tumors and the most sensitive test for extrahepatic tumors. FDG-PET alters management in 25% of patients, reducing futile laparotomies and hepatectomies.
authors.affiliation: Section of Hepato-Pancreato-Biliary Surgery, Department of Surgery, Washington University in St. Louis, St. Louis, MO, USA. strasbergs@wustl.edu
authors.forename: Steven M
authors.initials: SM
authors.lastname: Strasberg
authors.forename: Farrokh
authors.initials: F
authors.lastname: Dehdashti
mesh_terms: D015179:Colorectal Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology / Q000601:surgery; D019788:Fluorodeoxyglucose F18; D006498:Hepatectomy; D006801:Humans; D008113:Liver Neoplasms / Q000000981:diagnostic imaging* / Q000556:secondary / Q000601:surgery; D009367:Neoplasm Staging; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18